- Report
- July 2024
- 117 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- February 2024
- 148 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- February 2024
- 118 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- April 2023
- 105 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- April 2023
- 110 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- April 2023
- 115 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- April 2023
- 120 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- November 2023
- 77 Pages
France
From €3114EUR$3,500USD£2,689GBP
- Report
- May 2024
- 200 Pages
Global
From €3692EUR$4,150USD£3,188GBP
- Report
- May 2024
- 200 Pages
Global
From €3692EUR$4,150USD£3,188GBP
- Report
- March 2024
- 200 Pages
Global
From €3692EUR$4,150USD£3,188GBP
- Report
- January 2024
- 200 Pages
Global
From €3692EUR$4,150USD£3,188GBP
- Report
- October 2023
- 145 Pages
Global
From €2802EUR$3,150USD£2,420GBP
- Report
- January 2024
- 90 Pages
Africa, Middle East
From €3069EUR$3,450USD£2,650GBP
- Report
- March 2023
- 211 Pages
Global
From €3959EUR$4,450USD£3,419GBP
- Report
- December 2023
- 150 Pages
Global
From €3167EUR$3,560USD£2,735GBP
€3959EUR$4,450USD£3,419GBP
- Report
- July 2023
- 148 Pages
Europe
From €3069EUR$3,450USD£2,650GBP
- Report
- July 2023
- 255 Pages
Global
From €1112EUR$1,250USD£960GBP
€2224EUR$2,500USD£1,921GBP
- Report
- April 2023
- 150 Pages
Global
From €3425EUR$3,850USD£2,958GBP
€4315EUR$4,850USD£3,726GBP
- Report
- July 2023
- 115 Pages
Global
From €4004EUR$4,500USD£3,457GBP

The mRNA market within the biotechnology industry is a rapidly growing sector that focuses on the development of messenger ribonucleic acid (mRNA) technology. mRNA is a type of genetic material that is used to create proteins and is a key component of gene therapy. mRNA technology has been used to develop treatments for a variety of diseases, including cancer, heart disease, and neurological disorders. mRNA technology has also been used to develop vaccines for infectious diseases.
The mRNA market is driven by the increasing demand for mRNA-based treatments and vaccines, as well as the growing number of applications for mRNA technology. Companies in the mRNA market are focused on developing mRNA-based treatments and vaccines, as well as developing new applications for mRNA technology. Some of the major companies in the mRNA market include Moderna, BioNTech, CureVac, and Arcturus Therapeutics. Show Less Read more